Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein

被引:202
|
作者
Nishida, N
Harris, DA
Vilette, D
Laude, H
Frobert, Y
Grassi, J
Casanova, D
Milhavet, O
Lehmann, S
机构
[1] CNRS, Inst Human Genet, UPR 1142, F-34396 Montpellier 5, France
[2] INRA, Unite Virol Immunol Mol, F-78352 Jouy En Josas, France
[3] CEA, Serv Pharmacol & Immunol, F-91191 Gif Sur Yvette, France
[4] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA
关键词
D O I
10.1128/JVI.74.1.320-325.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Propagation of the agents responsible for transmissible spongiform encephalopathies (TSEs) in cultured cells las been achieved for only a few cell lines. To establish efficient and versatile models for transmission, we developed neuroblastoma cell lines overexpressing type A mouse prion protein, MoPrPC-A, and then tested the susceptibility of the cells to several different mouse-adapted scrapie strains. The transfected cell clones expressed up to sixfold-higher levels of PrPC than the untransfected cells. Even after 30 passages, we were able to detect an abnormal proteinase R-resistant form of prion protein, PrPSc, in the agent-inoculated PrP-overexpressing cells, while no PrPSc was detectable in the untransfected cells after 3 passages. Production of PrPSc in these cells was also higher and more stable than that seen in scrapie-infected neuroblastoma cells (ScN2a). The transfected cells mere susceptible to PrPSc-A strains Chandler, 139A, and 22L but not to PrPSc-B strains 87V and 22A. We further demonstrate the successful transmission of PrPSc from infected cells to other uninfected cells. Our results corroborate the hypothesis that the successful transmission of agents ex vivo depends on both expression Levels of host PrPC and the sequence of PrPSc. This new ex vivo transmission model will facilitate research into the mechanism of host-agent interactions, such as the species barrier and strain diversity, and provides a basis for the development of highly susceptible cell lines that could be used in diagnostic and therapeutic approaches to the TSEs.
引用
收藏
页码:320 / 325
页数:6
相关论文
共 27 条
  • [21] Immortalization and characterization of osteoblast cell lines generated from wild-type and Nmp4-null mouse bone marrow stromal cells using murine telomerase reverse transcriptase (mTERT)
    Alvarez, Marta B.
    Childress, Paul
    Philip, Binu K.
    Gerard-O'Riley, Rita
    Hanlon, Michael
    Herbert, Brittney-Shea
    Robling, Alexander G.
    Pavalko, Fredrick M.
    Bidwell, Joseph P.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (05) : 1873 - 1882
  • [22] Pathogenicity assessment of wild-type and mouse-adapted influenza A(H1N1)pdm09 viruses in comparison with highly pathogenic influenza A(H5N1) virus
    Prokopyeva, E. A.
    Romanovskaya, A. A.
    Sharshov, K. A.
    Zaykovskaya, A. V.
    Alekseev, A. Yu.
    Shestopalov, A. M.
    HISTOLOGY AND HISTOPATHOLOGY, 2017, 32 (10) : 1057 - 1063
  • [23] Activation of immunological network by chronic low-dose-rate irradiation in wild-type mouse strains: Analysis of immune cell populations and surface molecules
    Ina, Y
    Sakai, K
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2005, 81 (10) : 721 - 729
  • [24] Comparative microarray analysis of basal gene expression in mouse Hepa-1c1c7 wild-type and mutant cell lines
    Fong, CJ
    Burgoon, LD
    Zacharewski, TR
    TOXICOLOGICAL SCIENCES, 2005, 86 (02) : 342 - 353
  • [25] Comparative analysis of the gut microbiota composition in the Cln1R151X and Cln2R207X mouse models of Batten disease and in three wild-type mouse strains
    Camille Parker
    Jing Zhao
    David A. Pearce
    Attila D. Kovács
    Archives of Microbiology, 2021, 203 : 85 - 96
  • [26] Comparative analysis of the gut microbiota composition in theCln1R151XandCln2R207Xmouse models of Batten disease and in three wild-type mouse strains
    Parker, Camille
    Zhao, Jing
    Pearce, David A.
    Kovacs, Attila D.
    ARCHIVES OF MICROBIOLOGY, 2021, 203 (01) : 85 - 96
  • [27] The combination of PARP inhibitor talazoparib with low-dose temozolomide results in increased cell lethality in BRCA1/2 wild-type melanoma, small cell lung cancer, ovarian, and colon cancer cell lines and mouse xenografts via the formation of DNA double-strand breaks during S-phase
    McCann, Kelly Elizabeth
    von Euw, Erika
    O'Brien, Neil
    Slamon, Dennis
    CANCER RESEARCH, 2020, 80 (16)